Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > E-Selectin

E-Selectin

Brief Information

Name:Selectin E
Target Synonym:LECAM2,ELAM1,Endothelial leukocyte adhesion molecule 1,ELAM-1,SELE,Selectin E,CD62 Antigen-Like Family Member E,Endothelial Adhesion Molecule 1,Leukocyte-Endothelial Cell Adhesion Molecule 2,CD62E Antigen,CD62E,ESEL,ELAM,E-Selectin,Leukocyte Endothelial Cell Adhesion Molecule 2
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 3 Clinical

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CDE-H5250 Human Human E-Selectin / CD62E Protein, Fc Tag
CDE-H5250-structure
CDE-H5250-sds
CDE-H5222 Human Human E-Selectin / CD62E Protein, His Tag
CDE-H5222-structure
CDE-H5222-sds
ACRO Quality

Synonym Name

SELE,RP1-117P20.2,CD62E,ELAM1,ESEL,LECAM2,E-Selectin

Background

E-Selectin is also known as CD62 antigen-like family member E (CD62E), endothelial-leukocyte adhesion molecule 1 (ELAM-1), or leukocyte-endothelial cell adhesion molecule 2 (LECAM2), a member of the Selectin family, is a 107-115 kDa cell surface glycoprotein. It is transiently expressed on vascular endothelial cells in response to IL-1β and TNFα. E selectin has a cassette structure: an N-terminal, C-type lectin domain, an EGF (epidermal-growth-factor)-like domain, 6 Sushi domain (SCR repeat) units, a transmembrane domain (TM) and an intracellular cytoplasmic tail (cyto). During inflammation, E-selectin plays an important part in recruiting leukocytes to the site of injury. The local release of cytokines IL-1 and TNF-α by damaged cells induces the over-expression of E-selectin on endothelial cells of nearby blood vessels. E-selectin mediates the adhesion of tumor cells to endothelial cells, by binding to E-selectin ligands expressed by neutrophils, monocytes, eosinophils, memory-effector T-like lymphocytes, natural killer cells or cancer cells. Furthermore, a number of studies have reported that levels of E-Selectin may be elevated in subjects with a variety of pathological conditions.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Uproleselan GMI-1271; APL-106 Phase 3 Clinical Glycomimetics Inc Leukemia; Down Syndrome; Coronavirus Disease 2019 (COVID-19); Neoplasms; Myelodysplastic Syndromes; Multiple Myeloma; Leukemia, Myeloid, Acute; Venous Thrombosis; Leukemia, Biphenotypic, Acute Details
E-selectin targeting humanized antibody (LifeArc) Phase 1 Clinical Lifearc Sepsis; Respiratory Distress Syndrome, Adult Details
GMI-1687 GMI-1687; APL-108 Phase 1 Clinical Glycomimetics Inc Leukemia, Myeloid, Acute; Inflammation; Anemia, Sickle Cell Details
PF-07209326 PF-07209326 Phase 1 Clinical Pfizer Inc Anemia, Sickle Cell Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap